Publications in collaboration with researchers from Instituto de Investigación Sanitaria de Navarra (14)

2025

  1. FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis

    Journal of Translational Medicine, Vol. 23, Núm. 1

  2. Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis

    Journal of Nanobiotechnology , Vol. 23, Núm. 1

  3. Intratumoral administration of Hibiscus sabdariffa-derived anthocyanins exerts potent antitumor effects in murine cancer models

    Frontiers in Immunology, Vol. 16

  4. Liposomal encapsulation of cholecalciferol mitigates in vivo toxicity and delays tumor growth

    Frontiers in Immunology, Vol. 16

2024

  1. Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

    Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284

  2. Peritoneal carcinomatosis in mouse models

    Methods in Cell Biology (Academic Press Inc.), pp. 67-78

2023

  1. Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure

    Molecular Therapy - Nucleic Acids, Vol. 33, pp. 599-616

2021

  1. Statins act as transient type i interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 7

2020

  1. Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

    Frontiers in Pharmacology, Vol. 11

  2. Long-Term Liver Expression of an Apolipoprotein A-I Mimetic Peptide Attenuates Interferon-Alpha-Induced Inflammation and Promotes Antiviral Activity

    Frontiers in Immunology, Vol. 11

  3. Scavenger Receptor Class B Type I is Required for 25-Hydroxycholecalciferol Cellular Uptake and Signaling in Myeloid Cells

    Molecular Nutrition and Food Research, Vol. 64, Núm. 15

2019

  1. Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a

    Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704

2017

  1. Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

    Oncotarget, Vol. 8, Núm. 3, pp. 5247-5255

2016

  1. Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function

    OncoImmunology, Vol. 5, Núm. 8